USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Oncoscope, Inc.
Address:
324 BLACKWELL ST, STE 1120
DURHAM, NC 27701-3658
Phone:
(919) 323-1807
URL:
N/A
EIN:
205020734
DUNS:
16751293
Number of Employees:
6
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $277,854.00 2
SBIR Phase II $2,988,333.00 1

Award List:

SBIR Phase I: Innovation for an Easy to Use Clinical a/LCI System for in Vivo Detection of Precancer

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$127,934.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project seeks to develop new clinical instrument for detecting early stage cancer in human epithelial tissues, the origin of most cancers. The instrument is based on a novel optical spectroscopic technology which is capable of providing… More

SBIR Phase I:Large Area Scanning a/LCI for Endoscopic Precancer Detection

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$149,920.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project seeks to develop a new clinical instrument capable of using a novel optical technology to scan large areas of epithelial tissue for the detection and localization of precancers. The optical technology, angle-resolved Low Coherence… More

Validation and commercialization of a/LCI for detection of esophageal neoplasia

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,988,333.00
Agency:
HHS
Principal Investigator:
Steven C. Gebhart – 919-251-8030
Abstract:
DESCRIPTION (provided by applicant): The objective of this research is to commercialize a device (the Oncoscope Panocyte system) used to guide biopsy selection in patients with Barrett's esophagus (BE) during standard endoscopy surveillance for early- stage esophageal cancer. Barrett's… More